The practice of sleep medicine is expanding and evolving rapidly, often ahead of the
evidence base to support clinical practice. Obstructive Sleep Disordered Breathing (SDB) is …

Background: Obstructive sleep apnoea syndrome (OSAS) affects an estimated 2–4% of the
middle aged population. Meta-analyses of randomised controlled trials have shown that the …

Sleep apnoea is associated with increased mortality and morbidity. The treatment goal is to
reduce the neurocognitive and cardiovascular sequelae. CPAP therapy in sleep apnoea is …

Rationale: Twenty-eight percent of people with mild to moderate obstructive sleep apnea
experience daytime sleepiness, which interferes with daily functioning. It remains unclear …

Background: It is unclear whether continuous positive airway pressure (CPAP), the treatment
of choice for severe obstructive sleep apnoea (OSA), is effective at improving outcomes in …

ABSTRACT CPAP is considered the gold standard treatment in OSA and is highly
efficacious in controlling OSA symptoms. However, treatment effectiveness is limited …

We conducted a systematic review of current evidence on the effectiveness of continuous
positive airway pressure (CPAP) for treatment of obstructive sleep apnoea–hypopnoea …

Continuous positive airway therapy (CPAP) remains the mainstay of therapy for obstructive
sleep apnea syndrome (OSAS). CPAP therapy has been demonstrated to resolve sleep …

Despite the high prevalence of obstructive sleep apnea (OSA) syndrome, no ideal therapy
has emerged to date. Based on recent randomized trials, continuous positive airway …

Randomised controlled trials (RCTs) of continuous positive airway pressure (CPAP) in
obstructive sleep apnoea (OSA) are time consuming, and their findings often inconclusive or …